Loading chat...
ME LD1734
Bill
Status
6/9/2025
Primary Sponsor
Matthea Larsen Daughtry
Click for details
AI Summary
-
Expands Maine's existing sales tax exemption for prescription medicines to include over-the-counter medicines and drugs labeled according to FDA requirements under 21 CFR Section 201.66
-
Covered OTC products include anesthetics, antacids, antibacterial/antifungal/antiviral medicines, antiseptics, astringents, contraceptive supplies and devices, eye/ear/nose medications, opioid antagonists, cough/cold/asthma/allergy products, and steroidal medicines
-
Explicitly excludes cannabis sales from the exemption
-
Effective date of January 1, 2026 for sales occurring on or after that date
-
Presented by Senate President Daughtry with bipartisan cosponsorship from 5 Senators and 4 Representatives
Legislative Description
An Act to Exempt Over-the-counter Medicines from the Sales and Use Tax
Sales And Use Tax
Last Action
CARRIED OVER, in the same posture, to any special or regular session of the 132nd Legislature, pursuant to Joint Order SP 800.
6/25/2025